BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 476971)

  • 21. A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S).
    Meikle AW; Jubiz W; Hutchings MP; West CD; Tyler FH
    J Clin Endocrinol Metab; 1969 Jul; 29(7):985-7. PubMed ID: 5793454
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of serum 17 alpha-hydroxy progesterone in the diagnosis of virilizing congenital adrenal hyperplasia.
    Montalto J; Davies HE; Connelly JF
    Aust Paediatr J; 1977 Mar; 13(1):12-6. PubMed ID: 869786
    [No Abstract]   [Full Text] [Related]  

  • 23. [21-deoxycortisol. A new marker of virilizing adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Fiet J; Gueux B; Raux-Demay MC; Kuttenn F; Vexiau P; Gourmelen M; Couillin P; Mornet E; Villette JM; Brerault JL
    Presse Med; 1989 Dec; 18(40):1965-9. PubMed ID: 2531882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gas-liquid chromatography in the diagnosis of congenital adrenal hyperplasia.
    Bongiovanni AM; Parks JS; Ranke M; Kirkland R; Vaidya V; Tenore A
    J Steroid Biochem; 1974 Aug; 5(5):467-9. PubMed ID: 4456026
    [No Abstract]   [Full Text] [Related]  

  • 25. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasmatic 17-alpha-hydroxyprogesterone in congenital adrenal hyperplasia due to 21 hydroxylase deficiency, treated and untreated].
    Loras B; Roux H; Audi-Parera L; David M; Bertrand J
    Biomedicine; 1974 Jul; 21(7):317-22. PubMed ID: 4373095
    [No Abstract]   [Full Text] [Related]  

  • 27. Early diagnosis of 11 beta-hydroxylase deficiency in two siblings confirmed by analysis of a novel steroid metabolite in newborn urine.
    Hughes IA; Arisaka O; Perry LA; Honour JW
    Acta Endocrinol (Copenh); 1986 Mar; 111(3):349-54. PubMed ID: 3515819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum 21-deoxycortisol and 17-hydroxypregnenolone in parents of patients with congenital adrenal hyperplasia.
    Cassorla F; Tenore A; Parks JS; Marino J; Bongiovanni AM
    J Endocrinol Invest; 1980; 3(2):137-42. PubMed ID: 6248589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone secretion in congenital adrenal hyperplasia.
    Finkelstein JW; Boyar RM; Roffwarg HP; Kream J; Fukushima DK; Gallagher TF; Hellman L
    J Clin Endocrinol Metab; 1973 Jan; 36(1):121-4. PubMed ID: 4681876
    [No Abstract]   [Full Text] [Related]  

  • 30. [11-Deoxycortisol].
    Yamada Y; Sekihara H
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():335-8. PubMed ID: 20963879
    [No Abstract]   [Full Text] [Related]  

  • 31. Parallel radioimmunoassay for plasma cortisol and 11-deoxycortisol.
    Kao M; Voina S; Nichols A; Horton R
    Clin Chem; 1975 Oct; 21(11):1644-7. PubMed ID: 1164794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of serum cortisol and 11-deoxycortisol by liquid chromatography.
    Reardon GE; Caldarella AM; Canalis E
    Clin Chem; 1979 Jan; 25(1):122-6. PubMed ID: 761348
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of plasma 21-deoxycortisol radioimmunoassay and application to the diagnosis of patients with 21-hydroxylase deficiency.
    Milewicz A; Vecsei P; Korth-Schütz S; Haack D; Rösler A; Lichtwald K; Lewicka S; von Mittelstaedt G
    J Steroid Biochem; 1984 Aug; 21(2):185-91. PubMed ID: 6090811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid phase fluoroimmunoassay for 11-deoxycortisol in serum using 21-amino-17-hydroxyprogesterone.
    Watanabe F; Tsubota N; Kobayashi Y; Miyata O; Ninomiya I; Miyai K
    Steroids; 1982 Oct; 40(4):393-401. PubMed ID: 6820581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The simultaneous assay of cortisol and 17alpha-hydroxyprogesterone in the plasma of patients with congenital adrenal hyperplasia.
    Pham-Huu-Trung MT; Gourmelen M; Girard F
    Acta Endocrinol (Copenh); 1973 Oct; 74(2):316-30. PubMed ID: 4355076
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic effects of growth hormone therapy on plasma levels of 11-deoxycortisol and cortisol in growth hormone-deficient children.
    Castro-Magana M; Maddaiah VT; Collipp PJ; Angulo M
    J Clin Endocrinol Metab; 1983 Apr; 56(4):662-7. PubMed ID: 6300159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening tests for congenital adrenal hyperplasia.
    Franks RC
    J Clin Endocrinol Metab; 1972 Dec; 35(6):831-5. PubMed ID: 4634483
    [No Abstract]   [Full Text] [Related]  

  • 38. The inhibition by etomidate of the 11 beta-hydroxylation of cortisol.
    Fry DE; Griffiths H
    Clin Endocrinol (Oxf); 1984 May; 20(5):625-9. PubMed ID: 6744636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-automated high-performance liquid chromatographic method for the simultaneous assay of plasma cortisol and 11-deoxycortisol in the metyrapone test.
    Underwood RH; Bradwin GR; Moore TJ; Williams GH
    J Chromatogr; 1990 Mar; 526(1):180-5. PubMed ID: 2341530
    [No Abstract]   [Full Text] [Related]  

  • 40. Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.
    de Simone G; Tommaselli AP; Rossi R; Valentino R; Lauria R; Scopacasa F; Lombardi G
    Hypertension; 1985; 7(2):204-10. PubMed ID: 2984117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.